Elevance Health releases transcript of Q1 2026 earnings call

Elevance Health

Elevance Health

ELV

0.00
  • Elevance Health Q1 2026 earnings call drew CEO Gail Boudreaux, CFO Mark Kaye, investor relations head Nathan Rich, plus senior leaders Morgan Kendrick, Felicia Norwood, Aimee Dailey.
  • Adjusted diluted EPS reached $12.58; full-year adjusted diluted EPS guidance raised to at least $26.75.
  • Net investment income included about $1 per share from non-recurring valuation adjustments; management set 2027 growth target at least 12% off 2026 baseline of at least $25.75.
  • Company booked a $935 million accrual tied to historical CMS risk adjustment data submission; management expects sanctions will not take effect if prescribed steps are completed by July 31.
  • CarelonRx sales momentum ran ahead of plan with two marquee national wins; integrated medical-pharmacy clients delivered savings of more than $100 per member per month.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief on April 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.